# Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC - Inspection Records

Source: https://www.globalkeysolutions.net/companies/wyeth-biopharma-division-of-wyeth-pharmaceuticals-llc/0de9118f-18ec-45b8-b757-44f97c13c29c

> Inspection records and compliance data for Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC in Andover, MA. Access full analysis and detailed observations.

---

## Details

- Name: Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC
- FEI Number: 1222181
- City: Andover
- State: MA
- Country Name: United States
- Address Line 1: 1 Burtt Rd.
- Zip Code: 01810

## Related Documents

- [483 - Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC - Unknown Date](https://www.globalkeysolutions.net/records/483/wyeth-biopharma-division-of-wyeth-pharmaceuticals-llc/963fbbb7-ae34-41b3-b159-0019c8524637) — source: FDA, date: Invalid Date
- [FDA Inspection 1304580 - Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC - 2026-02-11](https://www.globalkeysolutions.net/records/fda_inspections/wyeth-biopharma-division-of-wyeth-pharmaceuticals-llc/7fe2f561-ac70-45eb-81ac-d14014ee75a6) — source: FDA, date: February 11, 2026
- [FDA Inspection 1304580 - Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC - 2026-02-11](https://www.globalkeysolutions.net/records/fda_inspections/wyeth-biopharma-division-of-wyeth-pharmaceuticals-llc/97de66a3-38df-4231-8616-827b2267fbc3) — classification: No Action Indicated (NAI), source: FDA, date: February 11, 2026
- [FDA Inspection 1223617 - Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC - 2023-10-13](https://www.globalkeysolutions.net/records/fda_inspections/wyeth-biopharma-division-of-wyeth-pharmaceuticals-llc/22d7cfbc-d24c-4694-920d-84b9472872b0) — classification: No Action Indicated (NAI), source: FDA, date: October 13, 2023
- [483 - Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC - 2023-09-19](https://www.globalkeysolutions.net/records/483/wyeth-biopharma-division-of-wyeth-pharmaceuticals-llc/7326d811-b200-4ac7-ae4e-783a9762d90c) — source: FDA, date: September 19, 2023
- [FDA Inspection 1218069 - Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC - 2023-09-19](https://www.globalkeysolutions.net/records/fda_inspections/wyeth-biopharma-division-of-wyeth-pharmaceuticals-llc/4558354a-c1cd-4ed5-8d55-a88d769f59fc) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 19, 2023
- [FDA Inspection 1218069 - Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC - 2023-09-19](https://www.globalkeysolutions.net/records/fda_inspections/wyeth-biopharma-division-of-wyeth-pharmaceuticals-llc/f4363d29-0083-495d-94cb-2f6416bd0726) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 19, 2023
- [483 - Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC - 2021-07-23](https://www.globalkeysolutions.net/records/483/wyeth-biopharma-division-of-wyeth-pharmaceuticals-llc/f26688a9-ebef-4b85-8e02-60e31c3b8b06) — source: FDA, date: July 23, 2021
- [483 - Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC - 2019-05-03](https://www.globalkeysolutions.net/records/483/wyeth-biopharma-division-of-wyeth-pharmaceuticals-llc/f5c92731-0fa2-4ec9-acaf-b10ee4f44051) — source: FDA, date: May 3, 2019
- [483 - Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC - 2019-01-17](https://www.globalkeysolutions.net/records/483/wyeth-biopharma-division-of-wyeth-pharmaceuticals-llc/a6583052-60a0-4c35-8b20-4c7cd6df9baf) — source: FDA, date: January 17, 2019
- [483 - Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC - 2017-04-28](https://www.globalkeysolutions.net/records/483/wyeth-biopharma-division-of-wyeth-pharmaceuticals-llc/c8d75329-d72d-429e-9706-037dbe88a7d5) — source: FDA, date: April 28, 2017
- [FDA Inspection 1020234 - Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC - 2017-04-28](https://www.globalkeysolutions.net/records/fda_inspections/wyeth-biopharma-division-of-wyeth-pharmaceuticals-llc/b828d047-46c7-47e5-9c09-1a563eee27a5) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 28, 2017
- [FDA Inspection 1020234 - Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC - 2017-04-28](https://www.globalkeysolutions.net/records/fda_inspections/wyeth-biopharma-division-of-wyeth-pharmaceuticals-llc/f122bb42-1ac1-4ff2-a255-0f95cfbe9412) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 28, 2017
- [FDA Inspection 988784 - Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC - 2016-09-30](https://www.globalkeysolutions.net/records/fda_inspections/wyeth-biopharma-division-of-wyeth-pharmaceuticals-llc/821cb434-f20b-4886-8feb-4ac5fdb96fd6) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 30, 2016
- [FDA Inspection 919172 - Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC - 2015-02-20](https://www.globalkeysolutions.net/records/fda_inspections/wyeth-biopharma-division-of-wyeth-pharmaceuticals-llc/a6219935-8f00-4291-b718-fec8e7927081) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 20, 2015
- [FDA Inspection 919172 - Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC - 2015-02-20](https://www.globalkeysolutions.net/records/fda_inspections/wyeth-biopharma-division-of-wyeth-pharmaceuticals-llc/b80511c3-870c-439b-91ae-03052438d5f3) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 20, 2015

## Related Companies

- [Sumitomo Chemical Co., Ltd.](https://www.globalkeysolutions.net/companies/sumitomo-chemical-co-ltd/3ce10d51-6999-467f-ac0e-cb6696a98aa5)
- [Divi's Laboratories Ltd. (Unit II)](https://www.globalkeysolutions.net/companies/divis-laboratories-ltd-unit-ii/b2498cb9-d277-498a-b32b-037e04f6feaf)
- [Cipla Limited](https://www.globalkeysolutions.net/companies/cipla-limited/cefc1473-6852-4af7-b996-0730dc0834bb)
- [Cambrex Profarmaco Milano Srl](https://www.globalkeysolutions.net/companies/cambrex-profarmaco-milano-srl/5855fd12-020f-4975-9bc0-f5358c581aef)
- [Pfizer Asia Manufacturing Pte Ltd.](https://www.globalkeysolutions.net/companies/pfizer-asia-manufacturing-pte-ltd/77c4ecfd-af67-404b-8091-9c254525198b)
- [Teva API India Private Ltd.](https://www.globalkeysolutions.net/companies/teva-api-india-private-ltd/aeeb5a05-7558-44f6-a08a-bb2f3d1aa3de)
- [SpecGx LLC](https://www.globalkeysolutions.net/companies/specgx-llc/715bb75a-8d3a-4469-9e6d-f617c2f39c93)
- [Eisai Co., Ltd. Kashima Plant](https://www.globalkeysolutions.net/companies/eisai-co-ltd-kashima-plant/70a3ccaf-c591-4ebf-952a-a2ee6a62e53c)
- [Cipla Ltd.](https://www.globalkeysolutions.net/companies/cipla-ltd/d90a952b-3052-4e33-9969-5db3f2bbae82)
- [Matrix Pharmacorp Private Limited](https://www.globalkeysolutions.net/companies/matrix-pharmacorp-private-limited/3cbdd9ae-291e-406d-9e2c-5479410bf998)

## Related Officers

- [Strategic Expert at NovoNordisk; Retired from FDA](https://www.globalkeysolutions.net/people/debra-m-emerson/58bd7fac-28eb-4369-b149-13a24cc00cf7)
- [issuing_officer](https://www.globalkeysolutions.net/people/jee-y-chung/0736677f-9719-44dc-9dab-60b610ac1a0a)
- [Senior Consumer Safety Officer - Pharmaceutical Quality](https://www.globalkeysolutions.net/people/sean-r-marcsisin/45c910a9-9019-4419-9af8-b1c9f3b1e976)
- [issuing_officer](https://www.globalkeysolutions.net/people/aimee-cunningham/c49df6e2-a332-4f77-890f-213e3b3ddfb7)